XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENT OF SHAREHOLDERS EQUITY - USD ($)
$ in Millions
Total
Common stock
Capital in excess of par value
Retained earnings
Accumulated  other comprehensive (loss) income
Treasury stock
Non-controlling interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock, shares issued 128,526,137            
Treasury Stock, Shares (21,588,147)            
Beginning Balance at Dec. 31, 2020 $ 6,322 $ 16 $ 3,853 $ 4,156 $ (698) $ (1,017) $ 12
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (41)     (42)     1
Cumulative translation adjustment (417)       (417)    
Gains (losses) on derivatives qualifying as hedges; net of tax 4       4    
Pension and postretirement net liability 9       9    
Cash dividends declared (192)     (192)      
Stock options/SSARs 6   1     $ 5  
Stock options/SSARs, shares           98,729  
Vested restricted stock units and awards 0   (4)     $ 4  
Vested restricted stock units and awards, shares           82,461  
Impact of N&B Merger $ 15,980 18 15,936       26
Impact of N&B Merger (in shares) 141,740,461            
Stock-based compensation $ 11   11        
Redeemable NCI (1)   (1)        
Ending Balance at Mar. 31, 2021 $ 21,681 34 19,796 3,922 (1,102) $ (1,008) 39
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock, shares issued 270,266,598            
Treasury Stock, Shares (21,406,957)            
Common stock, shares issued 275,726,629            
Treasury Stock, Shares (21,152,645)            
Beginning Balance at Dec. 31, 2021 $ 21,117 35 19,826 3,641 (1,423) (997) 35
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 246     244     2
Cumulative translation adjustment (199)       (199)    
Gains (losses) on derivatives qualifying as hedges; net of tax 0            
Cash dividends declared (202)     (202)      
Stock options/SSARs 13   9     $ 4  
Stock options/SSARs, shares           80,153  
Vested restricted stock units and awards (15)   (22)     $ 7  
Vested restricted stock units and awards, shares           150,610  
Stock-based compensation 9   9        
Purchases of NCI (4)   1       (5)
Ending Balance at Mar. 31, 2022 $ 20,965 $ 35 $ 19,823 $ 3,683 $ (1,622) $ (986) $ 32
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock, shares issued 275,726,629            
Treasury Stock, Shares (20,921,882)